Healthpeak Properties (NYSE:DOC) Releases FY 2024 Earnings Guidance

Healthpeak Properties (NYSE:DOC) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 1.560-1.580 for the period, compared to the consensus estimate of 1.790. The company issued revenue guidance of -. Healthpeak Properties also updated its FY24 guidance to $1.79-1.81 EPS.

Healthpeak Properties Stock Performance

Shares of NYSE:DOC traded down $0.13 during midday trading on Thursday, reaching $22.99. 8,096,503 shares of the company traded hands, compared to its average volume of 5,663,726. The firm’s fifty day moving average price is $22.24 and its two-hundred day moving average price is $20.64. The firm has a market capitalization of $16.18 billion, a price-to-earnings ratio of 65.69, a price-to-earnings-growth ratio of 2.27 and a beta of 1.14. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.91. Healthpeak Properties has a 12 month low of $15.24 and a 12 month high of $23.26.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings results on Thursday, July 25th. The real estate investment trust reported $0.21 earnings per share for the quarter, missing the consensus estimate of $0.44 by ($0.23). Healthpeak Properties had a net margin of 11.93% and a return on equity of 3.51%. The company had revenue of $695.50 million for the quarter, compared to the consensus estimate of $665.11 million. During the same quarter in the prior year, the company earned $0.45 earnings per share. The company’s quarterly revenue was up 27.5% on a year-over-year basis. On average, equities analysts expect that Healthpeak Properties will post 1.8 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Scotiabank upped their price target on shares of Healthpeak Properties from $23.00 to $24.00 and gave the stock a “sector outperform” rating in a report on Monday, September 9th. Wedbush increased their price target on shares of Healthpeak Properties from $22.00 to $25.00 and gave the stock an “outperform” rating in a report on Monday, July 29th. Royal Bank of Canada lifted their price objective on shares of Healthpeak Properties from $22.00 to $25.00 and gave the stock an “outperform” rating in a report on Tuesday, July 30th. StockNews.com cut Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Saturday, October 19th. Finally, Citigroup lifted their price target on Healthpeak Properties from $20.00 to $22.00 and gave the stock a “neutral” rating in a research note on Thursday, August 22nd. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Healthpeak Properties has an average rating of “Moderate Buy” and a consensus price target of $22.62.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.